KPIs & Operating Metrics(New)
Adjusted Operating Income By Segment AnnualAdjusted Operating Margin By Segment Annual %Breakdown Of AssetsBusiness Unit Revenue Drug DevelopmentCapital ExpenditureContractual Obligations TotalCost Of RevenuesDepreciation And Amortization By SegmentEmployeeGoodwill By SegmentGross Margin %Gross ProfitIncome Before Income Taxes By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income By SegmentOperating Margin By Segment %Opex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment, Net BreakdownProperty, Plant And Equipment, Net By GeographyProperty, Plant And Equipment, Net By SegmentQuarterly Net Order Drug DevelopmentRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Base Business Diagnostics RevenueRevenue By Business VerticalRevenue By Business Vertical %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By PayerRevenue By Payer %Revenue By Payer AnnualRevenue By Payer Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue Mix Base Business Diagnostics Revenue %Revenue Per Employee %Revenuue Mix By Geography %Unearned Revenue
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Gross Profit (2016 - 2025)

Historic Gross Profit for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to $1.0 billion.

  • Labcorp Holdings' Gross Profit rose 1334.59% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 billion, marking a year-over-year increase of 1031.41%. This contributed to the annual value of $3.6 billion for FY2024, which is 771.2% up from last year.
  • Per Labcorp Holdings' latest filing, its Gross Profit stood at $1.0 billion for Q3 2025, which was up 1334.59% from $1.0 billion recorded in Q2 2025.
  • Labcorp Holdings' Gross Profit's 5-year high stood at $1.6 billion during Q1 2021, with a 5-year trough of $743.1 million in Q4 2021.
  • In the last 5 years, Labcorp Holdings' Gross Profit had a median value of $904.4 million in 2024 and averaged $992.7 million.
  • Data for Labcorp Holdings' Gross Profit shows a peak YoY increase of 11964.29% (in 2021) and a maximum YoY decrease of 6099.01% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Labcorp Holdings' Gross Profit stood at $743.1 million in 2021, then rose by 7.4% to $798.1 million in 2022, then increased by 2.92% to $821.4 million in 2023, then increased by 9.12% to $896.3 million in 2024, then increased by 14.37% to $1.0 billion in 2025.
  • Its Gross Profit stands at $1.0 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $948.0 million for Q1 2025.